Kanabo

Tel Aviv, Israel Founded: 2016 • Age: 10 yrs Listed Acquired By Spinnaker
Cannabis-based medical and consumer products are developed by Kanabo.

About Kanabo

Kanabo is a Healthcare company based in Tel Aviv (Israel) founded in 2016 by David Sack and Avihu Tamir, and was acquired by Spinnaker in December 2019. Cannabis-based medical and consumer products are developed by Kanabo. It operates on a Direct-to-Consumer (D2C), Reseller / Distribution, and HealthTech model. Kanabo has raised $1.08 million across 1 funding round from investors including Spinnaker. Kanabo has completed 1 acquisition, including The GP Service. Its chief executive, as recorded, is Avihu Tamir. Kanabo offers products and services including VapePod and Cannabis Formulas. Its focus areas include Pharmaceuticals and Medical Cannabis. Its legal entity is Kanabo Research Ltd.

Company details

Kanabo is engaged in the development and distribution of medical cannabis products, targeting both medical patients and CBD consumers. The company operates within the healthcare sector, specializing in high-quality cannabis oil formulas and innovative medical-grade vaporizers. Research and development activities are conducted in Israel, a leader in the cannabis industry, with clinical validation and safety tests performed to ensure product efficacy. Solutions include non-smoking consumption methods to make treatment accessible. Initial products are sold in Europe, with plans to scale operations to meet growing market demands.

  • Headquarters Tel Aviv, Israel
  • Founders David Sack, Avihu Tamir
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website kanabogroup.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by Spinnaker (Dec 2019)
  • Legal Name Kanabo Research Ltd.
Key Metrics

Products & Services of Kanabo

Kanabo offers a comprehensive portfolio of products and services, including VapePod and Cannabis Formulas.

VapePod
Medical Device

A certified vaporization device for cannabis extracts used.

Cannabis Formulas
Medical Cannabis

Formulas developed for CNS disorders and CBD markets.

Apps and channels of Kanabo

its YouTube channel Kanabo Research has 27 subscribers and 2 videos.

Kanabo Research
YouTube 27 subscribers 2 videos Science & Technology
Open channel

Videos from Kanabo

The most watched videos on Kanabo's YouTube channel, Kanabo Research (27 subscribers). Click a video to play it here.

Kanabo Research - Avihu Tamir // Pnina Strauss-Levy Lecture - Cannatech TLV 2018
545 views
Avihu Tamir interviewed on Proactive Investors
284 views

More on Kanabo Research.

Funding Insights of Kanabo

Kanabo has successfully raised a total of $1.08M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.08 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.08M
  • Total Rounds 1
  • Last Round Seed β€” $1.08M
  • First Round $1.08M

    (Mar 2020)

All 1 funding rounds of Kanabo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2020$1.08MSeed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Kanabo

Kanabo has secured backing from 1 investor. Prominent investors backing the company include Spinnaker.

All
InvestorDescriptionFounded YearDomainLocation
spinnakeropportunities.uk
Premium access

Investor details for Kanabo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Kanabo

2 people are tracked at Kanabo (2 in leadership).

NameRoleGroup
David Sack
Co-FounderLeadership
Avihu Tamir
Founder & CEOLeadership
Premium access

Complete people profiles for Kanabo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kanabo

Kanabo has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include The GP Service.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Online doctor consultations and pharmacy home delivery are offered.
thegpservice.co.ukLeicester, United Kingdom2014Feb 2022$18.19M
Premium access

Complete acquisition details for Kanabo

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Kanabo

5 dated milestones of Kanabo across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Kanabo is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Exit Acquired by Spinnaker.
  4. Funding First funding round of $1.1M.
  5. Acquisition Acquires The GP Service.

Web traffic of Kanabo

The website of Kanabo (kanabogroup.com) receives about 3.5K visits a month.

  • Monthly visits
    3.5K

    ▲ 33.4% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kanabo

Premium access

Complete news archive for Kanabo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanabo

Kanabo was founded in 2016 and raised its 1st funding round 4 years after it was founded.

Kanabo is headquartered in Tel Aviv, Israel.

Avihu Tamir is the CEO of Kanabo, as recorded in our data. They have also founded this company.

Kanabo is a funded company, having raised a total of $1.08M across 1 funding round to date. The company's 1st funding round was a Seed of $1.08M, raised on Mar 2020.

Kanabo is engaged in the development and distribution of medical cannabis products, targeting both medical patients and CBD consumers. The company operates within the healthcare sector, specializing in high-quality cannabis oil formulas and innovative medical-grade vaporizers. Research and development activities are conducted in Israel, a leader in the cannabis industry, with clinical validation and safety tests performed to ensure product efficacy. Solutions include non-smoking consumption methods to make treatment accessible. Initial products are sold in Europe, with plans to scale operations to meet growing market demands.

Kanabo offers VapePod and Cannabis Formulas.

Kanabo has made 1 acquisition, including The GP Service.

Kanabo has 1 investor. Key investors include Spinnaker.

Kanabo operates through Kanabo Research Ltd..

Yes. Kanabo was acquired by Spinnaker in December 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available